683a15fbc782e11e38d1b0f5
1787
4Ts Score for Heparin-Induced Thrombocytopenia
4Ts Score for Heparin-Induced Thrombocytopenia
4Ts for HIT
Differentiates patients with HIT from those with other causes of thrombocytopenia.
HIT vs other causes of thrombocytopenia.
4ts-score-heparin-induced-thrombocytopenia
The 4Ts Score is a clinical scoring system to differentiate patients with HIT from those with other causes of thrombocytopenia.
4 Ts for HIT, HIT calculator, heparin score, diagnosis HIT calc, heparin induced calculator, heparin coagulopathy score, heparin thrombocytopenia score
[ "Bleeding" ]
The 4TS Score is calculated by the addition of the selected points:
[]
{ "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Original/Primary Reference": [ { "href": "https://www.ncbi.nlm.nih.gov/pubmed/16634744", "text": "Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759–65." } ], "Other References": [], "Outcomes": [], "Validation": [ { "href": "https://www.ncbi.nlm.nih.gov/pubmed/23322137", "text": "Vatanparast R, Lantz S, Ward K, Crilley PA, Styler M. Evaluation of a pretest scoring system (4Ts) for the diagnosis of heparin-induced thrombocytopenia in a university hospital setting. Postgrad Med. 2012 Nov;124(6):36-42." } ], "Validations": [] }
The 4Ts for the diagnosis of heparin-induced thrombocytopenia (HIT) is a tool developed to help clinicians rule out HIT in patients who develop thrombocytopenia in the clinical setting.
Points to keep in mind:
A subsequent review and meta-analysis of the 4Ts scoring system for HIT found that patients in the low-risk group had a negative predictive value of 0.998, irrespective of type of clinician, prevalence of HIT, or patient population.
Consider using the 4Ts scoring system as an alternative evaluation tool prior to time-consuming antibody testing for HIT or empiric substitution of heparin for another anti-coagulant.
Low Probability (score 0-3): HIT is unlikely but continue to monitor platelet counts.
Intermediate Probability (score 4-5): HIT is possible.
High Probability (score 6-8): HIT is likely.
[ "Bleeding/Hemorrhage", "Thrombocytopenia" ]
{ "conditionality": null, "default": 2, "label_en": "Thrombocytopenia", "mdcalc_info_concept": null, "name": "thrombocytopenia", "option_fhir_rules": null, "optional": false, "options": [ { "label": "Platelet count fall >50% AND platelet nadir ≥20", "value": 2 }, { "label": "Platelet count fall 30–50% OR platelet nadir 10–19", "value": 1 }, { "label": "Platelet count fall <30% OR platelet nadir <10", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": null, "default": 2, "label_en": "Timing of platelet count fall", "mdcalc_info_concept": null, "name": "platelet_fall_timing", "option_fhir_rules": null, "optional": false, "options": [ { "label": "Clear onset between days 5–10 OR platelet fall ≤1 day (prior heparin exposure within 30 days)", "value": 2 }, { "label": "Consistent with days 5–10 fall, but not clear; onset after day 10 OR fall ≤1 day (prior heparin exposure 30–100 days ago)", "value": 1 }, { "label": "Platelet count fall <4 days without recent exposure", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": null, "default": 2, "label_en": "Thrombosis or other sequelae", "mdcalc_info_concept": null, "name": "thrombosis", "option_fhir_rules": null, "optional": false, "options": [ { "label": "New thrombosis OR skin necrosis; acute systemic reaction post-IV heparin bolus", "value": 2 }, { "label": "Progressive OR recurrent thrombosis; non-necrotizing skin lesions; suspected thrombosis (not proven)", "value": 1 }, { "label": "None", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": null, "default": 2, "label_en": "Other causes for thrombocytopenia", "mdcalc_info_concept": null, "name": "other_causes_thrombocytopenia", "option_fhir_rules": null, "optional": false, "options": [ { "label": "None apparent", "value": 2 }, { "label": "Possible", "value": 1 }, { "label": "Definite", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }
[ { "conditionality": null, "default": 2, "label_en": "Thrombocytopenia", "mdcalc_info_concept": null, "name": "thrombocytopenia", "option_fhir_rules": null, "optional": false, "options": [ { "label": "Platelet count fall >50% AND platelet nadir ≥20", "value": 2 }, { "label": "Platelet count fall 30–50% OR platelet nadir 10–19", "value": 1 }, { "label": "Platelet count fall <30% OR platelet nadir <10", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": null, "default": 2, "label_en": "Timing of platelet count fall", "mdcalc_info_concept": null, "name": "platelet_fall_timing", "option_fhir_rules": null, "optional": false, "options": [ { "label": "Clear onset between days 5–10 OR platelet fall ≤1 day (prior heparin exposure within 30 days)", "value": 2 }, { "label": "Consistent with days 5–10 fall, but not clear; onset after day 10 OR fall ≤1 day (prior heparin exposure 30–100 days ago)", "value": 1 }, { "label": "Platelet count fall <4 days without recent exposure", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": null, "default": 2, "label_en": "Thrombosis or other sequelae", "mdcalc_info_concept": null, "name": "thrombosis", "option_fhir_rules": null, "optional": false, "options": [ { "label": "New thrombosis OR skin necrosis; acute systemic reaction post-IV heparin bolus", "value": 2 }, { "label": "Progressive OR recurrent thrombosis; non-necrotizing skin lesions; suspected thrombosis (not proven)", "value": 1 }, { "label": "None", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": null, "default": 2, "label_en": "Other causes for thrombocytopenia", "mdcalc_info_concept": null, "name": "other_causes_thrombocytopenia", "option_fhir_rules": null, "optional": false, "options": [ { "label": "None apparent", "value": 2 }, { "label": "Possible", "value": 1 }, { "label": "Definite", "value": 0 } ], "show_points": true, "tips_en": "", "type": "radio" } ]
2022-04-21T20:29:01.352Z
[ "Diagnosis" ]
[ "plt", "HIT" ]
{ "keywords_en": "4 Ts for HIT, HIT calculator, heparin score, diagnosis HIT calc, heparin induced calculator, heparin coagulopathy score, heparin thrombocytopenia score", "meta_description_en": "The 4Ts Score is a clinical scoring system to differentiate patients with HIT from those with other causes of thrombocytopenia." }
[ "Critical Care", "Emergency Medicine", "Hematology and Oncology", "Hospitalist Medicine" ]
[ "Hematologic" ]
[]
1
[]
[ { "calcId": 1789, "short_title_en": "HIT Expert Probability (HEP) Score", "slug": "hit-expert-probability-hep-score-heparin-induced-thrombocytopenia" }, { "calcId": 4034, "short_title_en": "Corrected Count Increment (CCI) ", "slug": "corrected-count-increment-cci-platelet-transfusion" }, { "calcId": 10203, "short_title_en": "ISTH Criteria for DIC", "slug": "isth-criteria-disseminated-intravascular-coagulation-dic" } ]
true
[ "whenToUseViewed", "pearlsPitfallsViewed", "whyUseViewed", "nextStepsViewed", "evidenceViewed" ]
[ "hematology" ]
[ "Consider using the 4Ts scoring system to stratify patients’ risk for HIT in patients with thrombocytopenia who are currently or were recently on heparin derived agents.", "Patients falling into the low-risk category frequently do not need further testing for HIT.", "Consider further laboratory evaluation for HIT or switching to a non-heparin derived anti-coagulant in those patients in the intermediate or high-risk groups." ]
true